The 48th Annual William K. Ishmael Rheumatology Symposium and Second Annual Morris Reichlin Memorial Lectureship, 22015

Friday, April 1, 2022, 7:00 AM - 4:00 PM CST, Nicholson Conference Center, 940 NE 13th Street, 5th Floor


This intensive one day offering that includes a review and update on major subject areas in rheumatology. The faculty chosen to speak are recruited locally and from nationally recognized leaders in their fields.  The topics are chosen from the prior years participant suggestions.  The seminars are focused on practical diagnosis, treatment, and latest research in areas related to the successful delivery of rheumatology health care and patient outcomes. The University of Oklahoma College of Medicine faculty is nationally recognized for their expertise in the management of complex conditions that is unavailable elsewhere in the state, region or sometimes even the nation. This is a very fast-paced symposium with five lectures and one small group meeting.  Each session will include time for questions and answers. The course combines best practice strategies and education through case studies and lectures.

1. Discuss how genes and the environment are thought to interact in the pathogenesis of autoimmune diseases.
2. Describe modifiable and non-modifiable risk factors for autoimmunity.
3. Recognize potential strategies for prevention of autoimmune diseases, in particular among those at the highest risk.
4. Recognize the most common parenchymal pulmonary manifestations of various connective tissue diseases.
5. Recognize the implications for serologic testing in Interstitial Lung Disease (ILD) patients with and without a definitive connective tissue disease.
6. Use the treatment algorithms most commonly used in patients with connective tissue disease-associated interstitial lung disease (CTD-ILD).
7. Appraise recent advances in osteoarthritis molecular pathogenesis.
8. Recognize the importance of multidisciplinary approaches to refine translational target discovery.
9. Recognize possible cellular and molecular mechanisms responsible for rebound resorption.
10. Prevent bone loss after treatment with denosumab.
11. Recognize patterns of auto-inflammatory diseases.

Late Registration (3/22/2022):
Virtual Registration Fees:
Physician (MD, DO) Virtual, Late Rate - $125.00
Other Healthcare Providers ( PA, Nurses, PharmD, etc.) Virtual, Late Rate - $100.00
Non-Healthcare Virtual, Late Rate - $125.00

In-Person Registration Fees:
Physician (MD, DO) In-Person, Late Rate - $125.00
Other Healthcare Providers ( PA, Nurses, PharmD, etc.) In-Person, Late Rate - $100.00
Non-Healthcare In-Person, Late Rate - $125.00

Promo Virtual or In-Person *** Please contact Nicole L. Lung for promo code before registering. (405-271-2330 / [email protected])
*** OU Section of Rheumatology Faculty, Virtual - $100.00***
*** Fellows and VA Physician Assistants, Virtual - $100.00***
*** Residents & Medical Students, Virtual - $75.00***

*** OU Section of Rheumatology Faculty, In-Person - $100.00***
*** Fellows and VA Physician Assistants, In-Person - $100.00***
*** Residents & Medical Students, In-Person - $75.00***

*** Please contact Nicole L. Lung for promo code before registering. (405-271-2330 / [email protected])


Registration Notes:
• Registration Fee for Virtual attendance includes course materials and CME credit.
• Registration Fee for In-Person attendance includes course materials, food and CME credit.
• No registration refunds will be made after March 28, 2022.
• Written notification of cancellation must be postmarked before March 28, 2022.
• Cancellation fee is $25.
• Confirmations will be emailed. (This annual conference is subject to cancellation if registration is insufficient, in which case all registration fees will be refunded.)

The University of Oklahoma College of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

The University of Oklahoma College of Medicine designates this live activity for a maximum of 5.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

ANCC Accreditation Statement: 
OU Medicine, Inc. is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

CNE Disclosure Statements:
OU Medicine, Inc. is accredited with distinction as a provider of nursing continuing professional development by the American Nurses Credentialing Center’s Commission on Accreditation.

5.75 CNE contact hours will be awarded for meeting the following criteria: 90% attendance of conference, completion and submission of evaluation form.

This educational activity does not include any content that relates to the products and/or services of a commercial interest that would create a conflict of interest.

       ABIM MOC Recognition Statement:
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 5.75 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Within 60 days of the end of the session, ABIM MOC Points will be reported on your behalf.

For information about ACCME accreditation and ABIM MOC for this session, please email [email protected].

By providing your ABIM number, you consent to have the OUHSC CPD Office submit your participation in this activity to the ABIM through the ACCME PARS system.

     AAFP Accreditation Statement:
The AAFP has reviewed 48th Annual Ishmael Rheumatology Symposium and 2nd Annual Morris Reichlin Memorial Lectureship and deemed it acceptable for up to 5.75 Live AAFP Elective credits. Term of Approval is from 04/01/2022 to 04/01/2022. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Mitigation Statement: The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.

University Equal Opportunity / Non-Discrimination Statement:
The University of Oklahoma, in compliance with all applicable federal and state laws and regulations, does not discriminate on the basis of race, color, national origin, sex, sexual orientation, genetic information, gender identity, gender expression, age, religion, disability, political beliefs, or status as a veteran in any of its policies, practices, or procedures. This includes, but is not limited to: admissions, employment, financial aid, housing, services in educational programs or activities, or health care services that the university operates or provides.

To file a grievance related to the non-discrimination policy, report sexual misconduct, and/or file a formal complaint of sexual misconduct, please utilize the reporting form at link ou.edu/reportingform.

Inquiries regarding non-discrimination policies may be directed to the Office(s) of Institutional Equity as may be applicable – Norman campus: (405) 325-3546/3549, Health Sciences Center: (405) 271-2110, or OU-Tulsa Title IX Office: (918) 660-3107. Additionally, individuals may visit www.ou.edu/eoo.

Accommodation Statement:
For accommodations, please contact Nicole Lung at (405) 271-2330 or [email protected] as soon as possible.

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind, contributions given by a ineligible company, which is used to pay all or part of the costs of a CME activity.  An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. 

This activity received no commercial or in-kind support.

Disclaimer Statement:
Statements, opinions and results of studies contained in the program are those of the presenters and authors and do not reflect the policy or position of the Board of Regents of the University of Oklahoma (“OU”) nor does OU provide any warranty as to their accuracy or reliability.

Every reasonable effort has been made to faithfully reproduce the presentations and material as submitted. However, no responsibility is assumed by OU for any claims, injury and/or damage to persons or property from any cause, including negligence or otherwise, or from any use or operation of any methods, products, instruments or ideas contained in the material herein.

Policy on Faculty and Presenters Disclosure: 
It is the policy of the University of Oklahoma College of Medicine that the faculty and presenters identify all financial relationships with ineligible companies relating to the topics of this educational activity, and also disclose discussions of off-label or investigational drugs/devices and/or therapies during their presentation(s). 

AMA PRA Category 1 Credits™ (5.75 hours), AAPA Category 1 CME Credit (5.75 hours), ABIM MOC Part 2 (5.00 hours), American Academy of Family Phy Prescribed Credits (5.75 hours), ANCC Nursing Contact Hours (5.75 hours), Non-Physician Attendance (5.75 hours)

22015 Planning Committee
  Mary Beth Humphrey, MD, PhD – Course Director

   Nicole L. Lung, MS – Course Contact

  Jerry Carrell, PA-C

  Rabia S. Cheema, MD 

  Carol L. Davenport, MSN, RN-BC, NPD-BC 

  Matlock A. Jeffries, MD, FACP, FACR

  Aikaterina (Katherine) Thanou, MD

  Samera Vaseer, MD

Mitigation of Relevant Financial Relationships

The University of Oklahoma College of Medicine, Office of Continuing Professional Development has reviewed this activity’s speaker and planner disclosures and has mitigated all relevant financial relationships with ineligible companies, if applicable.

Friday, April 1, 2022

Acknowledgement of Commercial and In-Kind Support:
Commercial support is financial, or in-kind, contributions given by a ineligible company, which is used to pay all or part of the costs of a CME activity.  An ineligible company is one whose primary business is producing, marketing, selling, re-selling or distributing healthcare products used by or on patients. 

This activity received no commercial or in-kind support.

Please contact Nicole Lung at (405) 271-2330 or [email protected] for exhibitor information.